Search Results - "Zekri, Z. K."

A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results by Khaled, H. M., Zekri, Z. K., Mokhtar, N., Ali, N. M., Darwish, T., Elattar, I., Gaafar, R., Moawad, M. S.

“…Background: The value of continuous-infusion chemotherapy (EPOCH) vs. the standard CHOP combination was evaluated in 78 patients with previously untreated…”
Get full text

Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma? by Abdel Rahman, Hany, Moussa, Emad A.H., Zekri, Wael Z.K., El Debawy, Eman, Mostafa, Naglaa E., Yones, Alaa, Ezzat, Sameera, El Rahman Rayan, Abd

“…Neuroblastoma is the most common extracranial and deadly solid tumor in children. It accounts for 15% of the deaths from cancer in the pediatric age group…”
Get full text